We are thrilled to share a landmark, multi-company validation showing home-cage monitoring detects CNS safety signals missed by traditional Irwin/FOB testing. Home Cage Analyzer offers welfare benefits, and increased sensitivity for 24/7 data capture!
This collaborative validation demonstrates that HCA can uncover clinically relevant behavioral effects that traditional episodic assessments simply don’t capture. 24x7 automated home-cage monitoring (HCA) delivers earlier warning of CNS effects, improves animal welfare, and reduces costs across the drug discovery pipeline.
The work involved scientists from Actual Analytics, the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), AstraZeneca, GSK, Janssen Pharmaceuticals, Charles River Laboratories, ICON plc, and The University of Edinburgh. Learn more about ActualHCA: https://bocascientific.com/products/home-cage-analyzer
Read the published paper: https://lnkd.in/euV-GpZZ
View the press release: https://bocascientific.com/images/pdf/Actual_Analytics-Press_release.pdf